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Candida albicans is commonly found in mixed infections with Pseudomonas aeruginosa,
especially in the lungs of cystic fibrosis (CF) patients. Both of these opportunistic
pathogens are able to form resistant biofilms and frequently infect immunocompromised
individuals. The interaction between these two pathogens, which includes physical
interaction as well as secreted factors, is mainly antagonistic. In addition, research
suggests considerable interaction with their host, especially with immunomodulatory lipid
mediators, termed eicosanoids. Candida albicans and Pseudomonas aeruginosa are
both able to utilize arachidonic acid (AA), liberated from the host cells during infection,
to form eicosanoids. The production of these eicosanoids, such as Prostaglandin E2,
by the host and the pathogens may affect the dynamics of polymicrobial infection and
the outcome of infections. It is of considerable importance to elucidate the role of
host-produced, as well as pathogen-produced eicosanoids in polymicrobial infection.
This review will focus on in vitro as well as in vivo interaction between C. albicans and
P. aeruginosa, paying special attention to the role of eicosanoids in the cross-talk between
host and the pathogens.
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INTRODUCTION
Recently it has become increasingly evident that microorganisms are not only found as free floating
cells, but exist as surface associated, structured and cooperative consortia, called biofilms (Douglas,
2003; Hentzer et al., 2003; Burmølle et al., 2006; Harriott and Noverr, 2011). In addition, these
communities are embedded in an extracellular matrix of self-produced polymeric material. In
these interactive organizations for microorganisms secreted factors and physical proximity enable
metabolic interactions (Diaz et al., 2014). This often involves interkingdom interactions necessary
for ecological balance and survival of certain species (Rinzan, 2009).
Pseudomonas aeruginosa is a Gram-negative, aerobic rod colonizing a remarkable assortment of
niches, including aquatic environments, terrestrial environments and eukaryotic organisms (Pier,
1985; Tan et al., 1999). It is an opportunistic pathogen, frequently isolated from healthy humans as
part of the human microbiota and is commonly found in mixed infections with the yeast, Candida
albicans (Kaleli et al., 2006). Candida albicans is found as part of the normal microbiota of the
skin, gastrointestinal tract and female genital tract (Morales and Hogan, 2010) and is a major cause
of opportunistic infections ranging from superficial to fatal systemic infections (Sandven, 2000).
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Fungal infections have become increasingly troublesome in the
past decades, especially in immunocompromised patients and in
the hospital setting, with C. albicans being the most frequently
isolated fungal pathogen and the most commonly isolated
bloodstream pathogen (Rinzan, 2009). Selective pressure of
nutrient limitation and competition between bacteria and fungi
regulate the colonization of potential pathogenicmicroorganisms
such as C. albicans and P. aeruginosa, with a disruption in this
equilibrium resulting in infection by opportunistic pathogens
(Calderone and Fonzi, 2001).
These two microorganisms have tendencies to form
polymicrobial biofilms and as such play extensive roles in
nosocomial infections, infection in immunocompromised
individuals and especially in cystic fibrosis (CF) patients (El-
Azizi et al., 2004; Bianchi et al., 2008; McAlester et al., 2008).
This review, therefore, aims to evaluate the complex cross-
kingdom relationship of these two pathogens and the impressive
interaction and communication between them as well as the
collateral damage to hosts caught in the cross-fire. Additionally,
special attention will be given to the known immunomodulatory
lipids produced by both of these microorganisms as well as the
host and the role this may play during infection.
PATHOGENESIS OF PSEUDOMONAS
AERUGINOSA
Pseudomonas aeruginosa possesses numerous virulence factors
including exotoxin A, proteases and lipases, released by a type
II secretion system (Xcp regulon), as well as exotoxins exoS,
T, U, and Y, secreted into host cells by a type III secretion
system (Hogardt et al., 2004). Interestingly, it was found that P.
aeruginosa possesses two type II secretory pathways, previously
not seen in one organism (Ball et al., 2002). Additionally,
pyoverdine, rhamnolipids, lipopolysaccharide (LPS) and pili
also form part of this formidable pathogen’s virulence arsenal
(Gilligan, 1991; Méar et al., 2013). A study by Bianchi et al.
(2008) showed that P. aeruginosa impairs the engulfment of
apoptotic cells through the action of yet another virulence
factor, the phenazine, pyocyanin (PYO) (Gibson et al., 2009).
Interestingly, it has been shown that multiple drug resistant
strains of P. aeruginosa show decreased production of PYO,
and thus have a reduction in virulence (Fuse et al., 2013).
As previously mentioned, P. aeruginosa forms biofilms, and
a universal model for the formation of P. aeruginosa biofilm
formation was suggested (O’Toole et al., 2000; Klausen et al.,
2003). According to this model, P. aeruginosa cells move by
means of flagella to an adequate surface and movement along
this surface is accomplished through type IV-pili. Cells aggregate,
leading to microcolony formation. During maturation, large
mushroom-shaped structures are formed. Klausen et al. (2003)
proposed an alternate model, with evidence indicating that
flagella do not play a role in the attachment of P. aeruginosa
cells. The formation of P. aeruginosa biofilms are, however, highly
dependent on the carbon source. Additionally, the circumstances
during growth, such as flow vs. stationary growth, might elicit
large morphological changes.
In addition to the previously mentioned factors, the resistance
of P. aeruginosa to antimicrobial agents is key to its pathogenic
capabilities. Various mechanisms for antibiotic resistance in
P. aeruginosa biofilms have been proposed (Drenkard, 2003).
These include the reduced transport of antimicrobial agents
in the biofilm due to extracellular matrix and accompanied
nutrient and oxygen limitation of cells deeply embedded in
the biofilm. This causes a decrease in metabolic activity of the
cells. Antibiotic resistant persisters embedded in the biofilm
structure, stress responses of the cells, eﬄux pumps and
quorum sensing among cells may all contribute to the increased
resistance observed in bacterial biofilms. Evidence also suggest
that a protein, PvrR, regulates susceptibility and resistance
phenotypes of P. aeruginosa (Drenkard and Ausubel, 2002;
Benamara et al., 2011). An impact on lipid composition is also
speculated due to differential protein expression in biofilms.
In this regard, Benamara et al. (2011) examined the effect
of biofilm formation on inner membrane lipid composition
in P. aeruginosa that indicated a reduced amount of uneven
numbered phospholipids. In addition, an increase in long
chain phosphatidylethanolamines was observed, suggesting an
increase in bilayer lipid stability and a decrease in membrane
fluidity.
PATHOGENESIS OF CANDIDA ALBICANS
Candida albicans is a dimorphic yeast, meaning that both yeast
and hyphal morphology is shown, with a tendency to form
drug resistant biofilms (Ramage et al., 2001). The ability of
this microorganism to switch between the planktonic single
yeast cell and hyphal morphologies has a major influence on
its virulence (Andes et al., 2004; Pierce, 2005; Bruzual et al.,
2007; Brand et al., 2008; Gil-Bona et al., 2015). In addition to
this morphological plasticity, the aggressiveness of C. albicans
colonization is due to a collection of other virulence factors.
These include adhesins (biomolecules that enable binding to host
cells or host cell ligands), lipolytic and proteolytic enzymes and
phenotypic switching (white to opaque switching) (Calderone
and Fonzi, 2001). Interaction of C. albicans with the host
is largely accomplished by contact with the C. albicans cell
surface and subsequent biofilm formation (Gow and Hube,
2012). Ramage et al. (2001) investigated the formation of
C. albicans biofilms through visualization of the biofilms at
various stages of development and monitoring the metabolic
activity of the cells. Through scanning electron microscopy
(SEM) and confocal scanning laser microscopy (CSLM) a dense
network of hyphae and yeast cells in a matrix of exopolymeric
material was visualized in the matured biofilm. This study also
tested the effect of antifungal drugs on Candida biofilms and
planktonic C. albicans cells. It was found that cells in the
biofilm had a 250-fold increase in resistance against fluconazole.
Dumitru et al. (2004) argued that this increased resistance
might be due to the hypoxic conditions found in biofilms, with
anaerobically grown C. albicans also showing resistance against
certain antifungal agents. Interestingly, a study by Kuhn et al.
(2002) evaluated a range of antifungal agents againstCandida and
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found that sub-inhibitory concentrations of certain antifungals
elicited alterations in biofilm formation.
INTERACTION BETWEEN PSEUDOMONAS
AERUGINOSA AND CANDIDA ALBICANS
IN VITRO
Physical/Direct Interaction
Several studies were conducted to evaluate the interaction of
P. aeruginosa and C. albicans. The antagonistic interaction of
C. albicans and P. aeruginosawas examined by Brand et al. (2008)
who showed that P. aeruginosa cells kill C. albicans hyphal cells,
but not C. albicans yeast cells. The deadly effect on C. albicans is
thought to be due to PYO, which alters the cell wall of C. albicans
(Kerr et al., 1999). Further research into this interaction provided
evidence that there is a difference in P. aeruginosa mediated
C. albicans killing among different morphotypes of C. albicans
(Rinzan, 2009). Increased susceptibility to the killing effect of
P. aeruginosa was seen with filamentous cells compared to
planktonic counterparts, similar to the study by Brand et al.
(2008), as well as a reversion of germ tube formation in the
presence of P. aeruginosa. Further analysis of this interaction
indicated that attachment of P. aeruginosa and C. albicans
killing is mediated by lectin-carbohydrate interaction, type IV
pili as well as mannans. The authors also speculated on the
possible involvement of O-linked mannans in the survival of
C. albicans yeast cells during combined incubation, as was
proposed previously (Brand et al., 2008; Rinzan, 2009). In
Figure 1, scanning electron micrographs of a dual species biofilm
with C. albicans and P. aeruginosa is seen showing extensive
colonization of C. albicans cells by P. aeruginosa.
Indirect Interaction
Role of Pseudomonas aeruginosa Quorum Sensing
Molecules during In vitro Interaction
The interaction of C. albicans and P. aeruginosa is mediated by
quorum sensing molecules (QSM), produced by both organisms
(Cugini et al., 2007). The bulk of Gram-negative bacterial
quorum sensing systems utilize N-acyl homoserine lactones
(AHL) that bind and activate their respective transcriptional
activators (R protein) to induce expression of target genes (de
Kievit and Iglewski, 2000). When adequate population density is
reached by bacterial cells, AHL concentrations are high enough
to induce these transcriptional changes.
Two AHL-dependent QS systems were identified in
P. aeruginosa, namely the las and rhl systems (de Kievit
and Iglewski, 2000). 3-oxododecanoyl-L-homoserine lactone
(3-oxo-HSL) is an autoinducer with its production directed by
LasI autoinducer synthase (las QS system). The production of
another autoinducer, butanoylhomoserine lactone, is similarly
regulated by RhlI autoinducer synthase (rhl QS system). These
bind and activate their respective transcriptional activators LasR
and RhlR (Passador et al., 1993; Pearson et al., 1995). These
QSMs may regulate up to 10% of the genome of P. aeruginosa
depending on culture conditions (Hentzer et al., 2003; Wagner
FIGURE 1 | Scanning electron micrographs of Candida albicans
colonized by Pseudomonas aeruginosa PAO1 showing adhesion to
C. albicans hyphae. Scale bars represent (A) 10µm and (B) 1µm.
Co-culture of C. albicans and P. aeruginosa was performed and visualized by
Ruan Fourie.
FIGURE 2 | Structures of (A) 3-oxododecanoyl-L-homoserine lactone
at the top and (B) butanoylhomoserine lactone underneath.
et al., 2003). The structures of these autoinducers are shown in
Figure 2.
The QSM, 3-oxo-HSL, was studied for its effect on cell
adherence in polymicrobial biofilms of P. aeruginosa and
C. albicans (Ovchinnikova et al., 2012). The study showed that
mutant P. aeruginosa strains lacking the lasI gene for the LasI
autoinducer synthase was unable to adhere to C. albicans hyphae,
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while a P. aeruginosa strain without the mutation was able to
adhere to C. albicans cells. The study suggested that 3-oxo-HSL
is needed for the adherence of P. aeruginosa cells to C. albicans
hyphae, because 3-oxo-HSL is needed for the production of
surface adherence proteins on P. aeruginosa cells. A study by
McAlester et al. (2008) showed that if cell free supernatant
from high 3-oxo-HSL producing P. aeruginosa strains is added
to C. albicans cultures, the yeast to hyphal switch is inhibited.
Pseudomonas aeruginosa strains that produced low amounts of
3-oxo-HSL did not inhibit the yeast to hyphal switch when the
supernatants of their cultures were added to C. albicans cultures,
suggesting that 3-oxo-HSL affects yeast morphology in a dose
dependent manner. To ensure that the 3-oxo-HSL was the cause
of the inhibition of morphological switch, pure 3-oxo-HSL was
added to a C. albicans culture with the same results obtained.
The reaction of C. albicans toward 3-oxo-HSL may lead to the
dispersal of C. albicans cells in the presence of P. aeruginosa
(Morales and Hogan, 2010; Ovchinnikova et al., 2012). These
studies thus show that AHLs are not only important for bacterial
communication, but are responsible for considerable interaction
with other microorganisms such as C. albicans.
In addition to AHLs, a QS signal, 2-heptyl-3-hydroxyl-
4-quinolone signal or Pseudomonas quinolone signal (PQS),
was later identified and this molecule is released in the late
exponential phase (Pesci et al., 1999; Lépine et al., 2003). The
production of PQS can be induced by the LasI/R system and
inhibited by the RhlI/R system (De Sordi and Mühlschlegel,
2009). Strikingly, PQS was shown to have both a damaging effect
on P. aeruginosa through a pro-oxidative effect, as well as an anti-
inflammatory effect (Haussler and Becker, 2008). The authors
speculate that this contradictory effect drives survival of the
fittest through selection of phenotypic variants able to survive
in stressful conditions and molding populations sufficiently
adapted. It also modulates swarming motility of P. aeruginosa
(Déziel et al., 2004; Ha et al., 2011). In addition to PQS, its
immediate precursor, 2-heptyl-4-quinolone (HHQ), has been
shown to repressC. albicans biofilm formation (Reen et al., 2011).
PQS (Figure 3A) induces the formation of several virulence
factors, including phenazine compounds (Phelan et al., 2014).
Of these, PYO or methyl-1-hydroxyphenazine (Figure 3B), is
the best studied. Pyocyanin is a chloroform soluble compound
with a blue color (Cox, 1986). It has been shown to be a
QSM produced in the early stationary phase (Hernandez et al.,
2004; Price-Whelan et al., 2007) and a study by Dietrich
et al. (2006) suggested that PYO is a terminal signaling
molecule that controls its own cycling. It plays a major role
in maintaining NADH/NAD+ ratio stability in P. aeruginosa
cells when they encounter oxygen limiting conditions due to
the limited fermentation capability of Pseudomonas (Dietrich
et al., 2006). Pyocyanin can then act as an alternate terminal
electron acceptor and decrease the NADH/NAD+ ratio in the
stationary phase of growth. It can then later be reoxidized
by oxygen when it becomes available and this could be a
mechanism for the production of reactive oxygen species (ROS).
Phenazines, including PYO, phenazine-1-carboxylic acid, 1-
hydroxyphenazine and phenazine-1-carboxamide play extensive
roles in the interaction between Pseudomonas species and
FIGURE 3 | Structures of (A) Pseudomonas quinolone signal at the top
and (B) pyocyanin underneath.
eukaryotes, including fungal microorganisms (Kaleli et al., 2006;
Phelan et al., 2014).
In addition, PYO has antimicrobial activity against a wide
range of cells including a bactericidal effect against a wide variety
of bacterial species with Gram-positive species being more
susceptible than Gram-negative species (Hassan and Fridovich,
1980). Interestingly, Pseudomonas species seem to be resistant to
this bactericidal effect (Baron and Rowe, 1981). It is also toxic
to eukaryotic cells (O’Malley et al., 2003). The mechanism of
this effect is due to the ability of this compound to undergo
non-enzymatic redox cycling intracellularly, resulting in the
generation of ROS (Gloyne et al., 2011). Another effect of PYO
is the reduction in cyclic adenosine monophosphate (cAMP)
(Kerr et al., 1999). This enables PYO to inhibit the shift
from yeast to hyphal morphology in C. albicans because the
yeast-mycelium transition is promoted by increased levels of
intracellular cAMP. Gibson et al. (2009) observed a red pigment
with the co-incubation of P. aeruginosa and C. albicans produced
during close proximity of the yeast and bacterial cells. This
pigment was localized in fungal cells. The authors speculate
that C. albicans enzymes participate in the formation of this
product intracellularly. The precursor of this red pigment was
identified as 5-methylphenazine-1-carboxylic acid (5-MPCA)
through the use of P. aeruginosa strains with disruptions in
the phenazine biosynthesis pathway. The presence of the red
pigmented compound was linked to significant repression of
C. albicans viability. In addition, a recent study indicated that
the phenazines, phenazine-1-ol, phenazine-1-carboxylic acid and
phenazine-1-carboxamide, has a synergistic effect with three
antifungals: fluconazole, itraconazole and clotrimazole against
Candida species (Kumar et al., 2014). This then suggests
that the presence of phenazine producing organisms such as
Pseudomonas can drastically alter the treatment of simultaneous
fungal infection.
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FIGURE 4 | Structure of farnesol.
The Role of Candida albicans Quorum Sensing
Molecules during In vitro Interaction
Candida albicans has also been shown to produce QSMs (Hornby
et al., 2001). The QSM, farnesol (Figure 4), inhibits germ
tube formation and also caused a morphological shift from
predominant mycelial state to predominant yeast morphology,
indicating the effect as 3-oxo-HSL. The effect on the morphology
of C. albicans is thought to be due to inhibition of the
Ras1-controlled pathway involved in hyphal growth (Morales
and Hogan, 2010). Recently, farnesol was identified to attract
macrophages in hosts (Hargarten et al., 2015). The authors
speculate that engulfment and movement of these immune
cells then aid in dissemination as macrophages are killed by
C. albicans after engulfment. Farnesol induces the generation
of ROS which could play a role in the competition of C.
albicans with bacteria. Resistance of C. albicans to oxidative
stress has also been shown to be linked, in part, to farnesol
(Westwater et al., 2005). A study by Cugini et al. (2007) indicated
that farnesol inhibits P. aeruginosa PQS and a subsequent
virulence factor, PYO, whose production is controlled by PQS,
in a dose dependent manner. Interestingly, there was no effect
on the overall growth of P. aeruginosa. Additionally, when
P. aeruginosa was co-cultured with C. albicans, reduction in
PQS and PYO produced by P. aeruginosa was also observed,
suggesting that high enough concentrations of farnesol is
produced by C. albicans to exert an effect on P. aeruginosa.
Later, the same research group found that C. albicans and its
secreted factors increase PQS and butanoylhomoserine lactone
in lasR defective mutants of P. aeruginosa, with a downstream
increase in phenazine production (Cugini et al., 2010). The
authors speculated that oxidative stress may trigger downstream
quorum sensing pathways.
As seen with proteomic analysis by Jones-Dozier (2008), a
possible decrease in virulence of P. aeruginosa is evident when
exposed to farnesol, due to alterations in protein expression
of P. aeruginosa subjected to this compound. In addition to
decreasing PQS and PYO production, farnesol inhibits swarming
motility in P. aeruginosa (McAlester et al., 2008). Rhamnolipids,
a class of glycolipids, play a role in swarming motility and has
been implicated as playing part in the development of ventilator
associated pneumonia (VAP) (Köhler et al., 2010). Due to the
fact that rhamnolipid production is partly regulated by PQS, the
mechanism of decreased swarming motility may be due to the
reduction in PQS production by farnesol.
Other Factors Influencing In vitro Interaction
Iron availability
In a study by Purschke et al. (2012), C. albicans exhibited a
lower metabolic activity in mixed biofilms with P. aeruginosa
when compared to single species biofilms. Secretome analysis of
the proteins of the single vs. mixed species biofilms revealed an
overall increase of secreted proteins of mixed species biofilms
of C. albicans and P. aeruginosa compared to the single species
counterparts. This increase was largely found to be due to
increased secreted proteins by P. aeruginosa. Interestingly, a large
proportion of the increased protein production was attributed
to a siderophore, pyoverdine, specific to Pseudomonas. This
increase in pyoverdine was thought to be due to the increased
iron utilization by the two species in the mixed biofilm. This
was confirmed by the addition of iron, which abolished the
production of pyoverdine. The authors speculated sequestration
of available iron by pyoverdine results in decreased availability to
C. albicans, although C. albicans is able to utilize iron bound to
certain other microbial siderophores. Recent evidence suggests
that this phenomenon may not be of importance during in vivo
interaction (Lopez-Medina et al., 2015). In this study, C. albicans
secreted factors significantly reduced pyoverdine and another
siderophore, pyochelin, expression by P. aeruginosa during
gastrointestinal colonization in a murine model. This decrease of
expression by P. aeruginosa was linked to diminished virulence
of P. aeruginosa with growth unaffected. The authors suspect the
heterogeneity of the biofilms between in vivo and in vitro studies
may cause the differential results.
Recently, Trejo-Hernández et al. (2014) found that hypoxia
influences the ability of P. aeruginosa to inhibit C. albicans
filamentation in vitro compared to aerobic conditions. This
was attributed to decreased AHL produced by P. aeruginosa
in the presence of C. albicans. Previously, it was shown
that hypoxic conditions promote filamentation in C. albicans
and reduces farnesol production and response to it (Dumitru
et al., 2004). Additionally, the authors also speculated that
competition for ironmay also be greater during hypoxia (Synnott
et al., 2010; Trejo-Hernández et al., 2014). Therefore, both the
interaction of P. aeruginosa with C. albicans, the concentration
of oxygen and iron competition influences the production
of AHLs (Trejo-Hernández et al., 2014). The authors also
found that proteins known to play roles in iron uptake in
P. aeruginosa through siderophores were upregulated in mixed
biofilms, confirming previous observations. Additionally, iron
supplementation increased the growth of P. aeruginosa in single
andmixed biofilms, with this effect not seen withC. albicans. This
increase in growth of the bacterium may increase the destruction
of the fungal population. Lamont et al. (2002) indicated that
pyoverdine may act as a signaling molecule to modulate other
virulence factors including exotoxin A and pyoverdine itself.
Because pyoverdine production is increased in mixed biofilms,
the virulence of P. aeruginosamight also be upregulated in mixed
biofilms (Trejo-Hernández et al., 2014). Additionally, PQS as
well as products of the PQS system including rhamnolipids and
PYO, were upregulated. A significant increase in P. aeruginosa
mutability frequency was seen with a large number of antibiotic
resistant mutant phenotypes arising over time. The authors
speculate that the decreased catalase activity observed in mixed
biofilms may result in increased oxidative stress, concomitantly
increasing mutability. In the case of C. albicans, the same trend
was seen with hypermutability arising with a high frequency
of antimicrobial resistant phenotypes, possibly attributed to
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the increased oxidative stress caused by PYO produced by P.
aeruginosa. Additionally, C. albicans iron dependant processes,
including aerobic respiration, were downregulated. Glycolytic
enzyme activity in C. albicanswas also altered, with PYO possibly
attributing to this and leading to other pathways for energy
utilization. To confirm the increased virulence of C. albicans and
P. aeruginosa in mixed biofilms, the authors used a rat infection
model. Candida albicans was shown to promote pathogenicity
of P. aeruginosa. Therefore, the ability of these pathogens to
compete for iron may alter population dynamics and influence
the nature of the interaction.
Bacterial cell wall components
In addition to various secreted factors produced by P. aeruginosa
in polymicrobial interaction (Holcombe et al., 2010), bacterial
LPS were shown to have adverse effects on Candida spp.
biofilms (Bandara et al., 2010). The same group later confirmed
these results by evaluating the effect of P. aeruginosa LPS
on C. albicans (Bandara et al., 2013). The study suggested a
decrease of C. albicans filamentation and biofilm metabolic
activity, including glycolysis, and growth with the addition of
high concentrations of P. aeruginosa LPS. In addition to this,
peptidoglycan was shown to trigger filamentation in C. albicans
(Xu et al., 2008).
Ethanol
Chen et al. (2014) evaluated the effect of C. albicans produced
ethanol on P. aeruginosa and found that ethanol stimulated
adhesion and biofilm formation of P. aeruginosa. In addition,
swarming motility by P. aeruginosa decreased and a stimulation
of phenazine derivatization and production of 5-MPCA by
P. aeruginosa in the presence of ethanol was observed. The
authors speculate that there is a positive feedback loop where
C. albicans ethanol production increases P. aeruginosa 5-MPCA
production and biofilm formation. In turn, 5-MPCA stimulates
ethanol production in C. albicans (Morales et al., 2013).
Extracellular DNA
A recent study also identified extracellular DNA as a large
factor in biofilm formation by C. albicans (Sapaar et al.,
2014). Low amounts of extracellular DNA (1.0µg/mL) was
shown to promote biofilm formation and increase biofilm
stability, whereas higher concentrations (10µg/mL) hampered
the formation of biofilms by C. albicans as well as the stability
of the biofilms. The study also indicated that the source of the
extracellular DNA, whether it is C. albicans, or from bacterial
sources such as P. aeruginosa, does not matter. This increase in
biofilm formation by C. albicans due to extracellular DNA may
increase the virulence of the fungus. Evidence also suggest that
the concentration of extracellular DNA can reach 4 mg/mL in
CF patient sputum samples, raising the question if this facet of
interaction might have clinical relevance (Sapaar et al., 2014).
A summary of several facets of interaction between C. albicans
and P. aeruginosa can be seen in Figure 5.
INTERACTION BETWEEN PSEUDOMONAS
AERUGINOSA AND CANDIDA ALBICANS
IN VIVO
A high number of C. albicans nosocomial infections are
polymicrobial with P. aeruginosa a frequent co-isolate in blood
stream infections and pneumonia (Lindsay and Hogan, 2014).
Kerr (1994) was the first to describe the anticandidal activity of
P. aeruginosa in vivo. The study evaluated lung infection of three
surgery patients postoperatively with inhibition of C. albicans
growth seen after P. aeruginosa colonization. This inhibition
was confirmed with the regrowth of C. albicans seen after
eradication of P. aeruginosa, even with fluconazole treatment.
Additional in vitro susceptibility experiments confirmed the
suppression of Candida growth by P. aeruginosa. Gupta et al.
(2005) evaluated 300 burn patients over 2 years and found
repression of Candida spp. in the presence of P. aeruginosa.
Several studies also indicate that prior colonization of Candida
may promote susceptibility of the host to P. aeruginosa infection
(Roux et al., 2009; Hamet et al., 2012; Xu et al., 2014).
Nseir et al. (2007) reported that antifungal treatment during
Candida spp. tracheobronchial colonization may be associated
with reduced risk for P. aeruginosa colonization. The case is
strengthened by Azoulay et al. (2006), who reported a possible
link between Candida colonization of the respiratory tract and an
increased risk for Pseudomonas VAP. Roux et al. (2013) reported
that the Th1-Th17 immune response, associated with Candida
colonization, caused a decrease in P. aeruginosa phagocytosis
by alveolar macrophages, the primary innate immune response
against bacterial invasion. The adaptive Th1-Th17 response
evoked by C. albicans invasion, is characterized by an increase in
interferon È(IFNÈ), as well as an increase in interleukin-17 (IL-
17) and decrease in IL-2. The authors suggest that the increase
in IFNÈ, associated with the Th1-Th17 response, is responsible
for the inhibition of bacterial phagocytosis, through inhibiting
expression of scavenger receptors on alveolar macrophages.
Remarkably, contradictory results to the notion that
P. aeruginosa infection is more aggressive after prior C. albicans
colonization, was provided by Ader et al. (2011). In a murine
model, C. albicans short term colonization prior to P. aeruginosa
colonization caused a reduction in P. aeruginosa bacterial
load compared to the absence of C. albicans colonization
(Ader et al., 2011). Additionally, a reduction in P. aeruginosa
induced lung injury was observed with the prior colonization of
C. albicans. Interestingly, this effect was reversed with treatment
by the antifungal caspofungin during C. albicans colonization.
Candida albicans initiates alveolar innate immunity in a murine
model, protecting the host against subsequent P. aeruginosa
infection (Mear et al., 2014). The authors showed that prior
C. albicans infection induces interleukin-17 (IL-17) and IL-
22 secretion through innate lymphoid cell recruitment. The
cytokines produced, induce the production of antimicrobial
peptides as well as the mobilization of phagocytic cells. In
a murine gut model, C. albicans secreted factors inhibited
expression of siderophores as well as cytotoxic molecules
by P. aeruginosa, reducing the virulence of the bacteria
(Lopez-Medina et al., 2015). Due to this, increased survival of
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FIGURE 5 | Illustration of competition between Candida albicans and Pseudomonas aeruginosa. Pseudomonas aeruginosa attaches to C. albicans hyphae
and kills hyphal cells through secreted hydrolytic enzymes such as hemolytic phospholipase C (PlcH) and phenazines such as pyocyanin and
5-methylphenazine-1-carboxylic acid (5-MPCA). 3-oxo-homoserine lactone produced by P. aeruginosa and phenazines inhibit filamentation by C. albicans, similar to
farnesol, produced by C. albicans. Pseudomonas aeruginosa lipopolysaccharide (LPS) inhibits C. albicans filamentation. Ethanol production is increased by the
fungus, inhibiting the motility of P. aeruginosa (adapted from Lindsay and Hogan, 2014).
the host was observed during co-incubation of P. aeruginosa
with C. albicans. Interestingly, Neely et al. (1986) demonstrated
increased mortality in a murine model when C. albicans infection
was preceded by P. aeruginosa. This reciprocal effect may also
be due to alterations in innate immune response, as Faure
et al. (2014) reported that the P. aeruginosa type III secretion
system induced IL-18 secretion causing substantial neutrophil
recruitment and host cell damage, and decreased IL-17 secretion
in a mouse model, possibly leading to the reduced clearance of
pathogens.
The co-infection of P. aeruginosa and C. albicans has been
well documented in cystic fibrosis (CF) patients. CF is one of
the most commonly encountered autosomal recessive disorders
found, with the occurrence varying in race (Andersen, 1938). The
disease is caused by a genetic disorder where a mutation exists
in the CF transmembrane conductance regulator (CFTR) gene
(Delhaes et al., 2012). CF is a disease with two pathophysiological
properties, namely pancreatic insufficiency with malnutrition
and also airway infections due to extremely viscous secretions
(Andersen, 1938). The increased viscosity of lung secretions
is thought to be due to the increased sodium absorption
of the respiratory epithelium and the defective regulation of
chloride ion secretion (Gilligan, 1991). This is thought to be the
reason why CF patients have comparatively dehydrated surface
liquid which leads to defective mucociliary clearance. The thick
bronchial mucus traps viral particles, fungal spores and bacteria
and provides a suitable environment for the fungal spores and
bacteria to grow, causing infection (Delhaes et al., 2012). Ninety
percent of deaths in CF are due to pulmonary dysfunction
and in effect, chronic airway infection (Gilligan, 1991). A study
by Güngör et al. (2013) evaluated the most prevalent fungal
colonization in Turkish CF patients. The most prevalent fungal
microorganisms isolated from these CF patients, were shown to
be C. albicans at 62.5% (30 patients). In addition, fungal-bacterial
co-colonization in the CF patients was shown to be 98.2% in
these C. albicans infections. The most frequent bacterial co-
colonizer of CF patients with C. albicans infections was found to
be Staphylococcus aureus (53.57%), with P. aeruginosa at 48.21%,
Staphylococcus maltophilia at 16.07% and Haemophilus influenza
at 5.97%. Other similar studies have also implicated S. aureus
and P. aeruginosa as the most prevalent bacterial species isolated
(Valenza et al., 2008; Williamson et al., 2011). Several studies
addressed the correlation between C. albicans and P. aeruginosa
in CF infection, with a recent study suggesting a significant
correlation (Conrad and Bailey, 2015). Discrepancies may arise
due to method of analysis and the population analyzed.
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PRODUCTION AND ROLE OF OXYLIPINS
DURING INFECTION
Lipids have crucial cellular significance, forming membranes,
as well as acting as cellular signals (reviewed by Tehlivets
et al., 2007). The latter is of great importance in multicellular
eukaryotic organisms. Although lipids as signaling molecules
have beenwell studied inmammals and plants, their roles in fungi
are not as well characterized.
Arachidonic acid (AA) or 5,8,11,14-eicosatetraenoic
acid (Figure 6A), a major constituent of the mammalian
phospholipids, together with its wide range of metabolites
(termed eicosanoids), have substantial roles as lipid signals
(Chilton et al., 1996), including modulation of the innate
immune response (Rodríguez et al., 2014). As the constituent
of cellular membranes, it is predominantly found in the sn2
position of phospholipids with incorporation into inflammatory
cells through CoA-dependant acyl transferases.
The metabolism of AA to form a plethora of lipid
mediators involve various pathways in vertebrates, including
the action of cyclooxygenases (COX), lipoxygenases (LOX),
monooxygenases (CYP450), and non-enzymatic (NE) pathways.
Cyclooxygenases, or prostaglandin endoperoxide synthases, are
enzymes catalyzing the insertion of two oxygen atoms in AA
(Marnett et al., 1999). In mammalian cells, two isoforms exist,
namely, COX-1, which is constitutively expressed, and COX-
2, which is inducible. The initial reaction of AA oxidation,
mediated by COX, yields prostaglandin G2 (PGG2) (Rodríguez
et al., 2014). Through peroxidase activity, PGG2 is reduced to
prostaglandinH2 (PGH2), which serves as a precursor for various
other immunomodulatory compounds, including prostaglandins
as well as thromboxanes. For example, further action by
Prostaglandin E synthase converts PGH2 to Prostaglandin E2
(PGE2) (Figure 6D).
Lipoxygenases are a large group of dioxygenases that catalyze
oxygen insertion into polyunsaturated fatty acids in animals,
plants as well as microorganisms (Kuhn and O’Donnell, 2006;
Brodhun and Feussner, 2011). The reaction of oxygenation
consists of various steps, starting with hydrogen abstraction,
followed by radical rearrangement and the insertion of oxygen.
In addition to oxygenation and hydroperoxidation, LOX also
catalyze the synthesis of leukotrienes, lipoxins and hepoxilins
through the combination of various enzymatic activities (Kuhn
and O’Donnell, 2006; Dennis and Norris, 2015). Various
isoforms of LOX exist with different stereospecificity and
activities, for example 12/15-LOX catalyze oxygenation and
hydroperoxidation of PUFAs at the 12 or 15 carbon position.
Various studies suggest that the 12/15-LOX can be induced
by interleukin-4 (IL4) and IL13, which are important in
the Th2 response. Additionally, 12/15-LOX is inhibited by
interferon È. The low expression of 12/15-LOX has been linked
to pro-inflammatory responses and has been implicated in
airway functions. Prostaglandin E2 has also been argued to
induce the expression of 12/15-LOX in neutrophils through
cAMP elevation. Various products of LOX have also been
implicated in anti-inflammatory responses in neutrophils. Many
LOX products, including hydroperoxy-eicosatetraenoic acids
(HPETEs) and hydroxy-eicosatetraenoic acids (HETEs) are
intermediate products leading to the formation of lipoxins and
leukotrienes (Dennis and Norris, 2015). The interaction of COX-
and LOX-derived lipid mediators as well as the combination of
these two pathways leads to the modulation of the inflammatory
response (Dennis and Norris, 2015). The non-steroidal anti-
inflammatory drug (NSAID), acetylsalicylic acid (ASA) (also
known as aspirin), was shown to acetylate COX isozymes
leading to the formation of 15(R)-HETE, which acts as LOX
substrate for the formation of lipoxins (Serhan, 2002). These
lipoxins are potent anti-inflammatory molecules, inhibiting
neutrophil recruitment and leukotriene formation. In addition
to these pathways, cytochrome P450s are also responsible for the
formation of epoxyeicosatetraenoic acids (EETs) from AA, with
concurrent modification to diHETEs, playing differential effects
on the host.
The effects of eicosanoids on mammalian cells are dependent
on the type of target tissue and the physiological state of these
tissues (Dennis and Norris, 2015). Considerable research is
being done to determine the eicosanoids that play a role in
host protection against pathogens during infection as they can
enhance the clearance of pathogens. For this review, the focus will
fall on lipid mediators in terms of C. albicans and P. aeruginosa
infection.
Role of Mammalian Oxylipins during
Pseudomonas aeruginosa Infection
Several studies have addressed the effect of various invading
pathogens on the production of PGE2 to gain a better
understanding of the immunological aspects of infection. In
mammalian cells, PGE2 is formed through the metabolism of
AA by the action of cyclooxygenase (COX-1 or COX-2) to
first form PGH2, followed by PGE synthases to form PGE2
(Murakami et al., 2003). Immune cells are the main source of
PGE2, although this compound is also produced by various other
cell types (Kalinski, 2012; Agard et al., 2013). It elicits a response
in mammalian cells through activation of four receptors,
designated EP1–EP4, with the effect dependent on the receptor
activated.
Pseudomonas aeruginosa pulmonary infection is associated
with an overproduction of PGE2 and concurrent decrease in
phagocytosis by alveolar macrophages (Ballinger et al., 2006;
Agard et al., 2013). This increase in PGE2 is due to the large
amount of AA released during P. aeruginosa infection, mediated
by ExoU, an intracellular phospholipase (König et al., 1996; Saliba
et al., 2005; Sadikot et al., 2007; Agard et al., 2013). As such
it plays a crucial role in initial infection and infiltration by P.
aeruginosa. The absence of ExoU in P. aeruginosa was linked
to diminished severity of infection and PGE2 production. The
importance of PGE2 during P. aeruginosa infection was seen
when a COX-2 inhibitor was employed, resulting in a decrease
in severity of infection by this pathogen (Sadikot et al., 2007).
Several other virulence factors also elicit changes in PGE2 levels.
The QSM 3-oxo-HSL produced by P. aeruginosa was shown to
induce COX-2 and, therefore, PGE2 production in human lung
fibroblasts (Smith et al., 2002). Similarly, P. aeruginosa PYO
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FIGURE 6 | Structures of (A) arachidonic acid (AA) at the top, followed by (B) 3-hydroxyeicosatetraenoic acid (3-HETE); (C) 15-HETE; (D) Prostaglandin
E2 at the bottom.
and LPS increased the release of PGE2 in urothelial cells in a
concentration dependent manner (McDermott et al., 2013).
Role of Pseudomonas aeruginosa
Oxylipins during Infection
A number of microorganisms including bacteria are able to
form eicosanoids (Lamacka and Sajbidor, 1995). Although the
presence of LOX in plants and animals has long been known,
their presence in lower eukaryotes and prokaryotes has only
recently been established, with P. aeruginosa one of the few
bacteria with typical LOX genes. Pseudomonas aeruginosa has
been found to possess a secretable 15-LOX, homologous to
mammalian LOX, producing 15-HETE (Figure 6C) which is
similar to host 15-HETE and elicits anti-inflammatory effects
on the host, through acting as a substrate for lipoxin formation
(Serhan, 2002; Vance et al., 2004). The formation of these
lipoxins may alter the severity of infection through inhibiting
neutrophil recruitment and generation of leukotrienes (Serhan,
2002). In addition to 15-HETE, P. aeruginosa is able to produce
a range of products including dihydroxy unsaturated fatty
acids such as 7,10-dihydroxy-8(E)-octadecenoic acid (DOD)
(Hou, 2008). In addition, the production of prostaglandins
and prostaglandin-analog compounds have been identified in
P. aeruginosa (Lamacka and Sajbidor, 1995), however, the
effect of these compounds during infection has not been
addressed.
Role of Mammalian Oxylipins during
Candida albicans Infection
The alteration of immune response is not unique to bacteria, but
plays a significant role as a virulence factor during C. albicans
infection. Candida albicans is able to metabolize AA, liberated
from host cells by host as well as yeast-derived phospholipase
A2 (Castro et al., 1994; Filler et al., 1994; Brash, 2001; Niewerth
and Korting, 2001; Theiss et al., 2006; Parti et al., 2010).
In addition, C. albicans can induce significant production of
PGE2 by mammalian cells (Filler et al., 1994; Deva et al.,
2001). Candida albicans mannans, forming part of the C.
albicans cell wall, can directly induce PGE2 production by
mammalian cells (Smeekens et al., 2010). In addition, the
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induction of the release of AA and the eicosanoid metabolites
from alveolar macrophages has been shown to be partly
regulated by mannose and β-glucan receptors interacting with
fungal cell wall components and have also been shown to
inhibit phagocytosis during C. albicans infection (Castro et al.,
1994).
Eradication of infection by the immune system is highly
dependent on the balance of Th1 and Th2 responses (Romani,
2000). The Th1 response is associated with the removal of
pathogens through phagocytosis, in contrast to the hampering
of this effect during the Th2 response. Prostaglandin E2
is able to modulate this balance and frequently promotes
colonization of pathogens such as C. albicans, as well as causing
tissue eosinophilia. Prostaglandin E2 production in response to
C. albicans invasion also induces the protective Th-17 response
in mammalian systems (Smeekens et al., 2010).
Role of Candida albicans Oxylipins during
Infection
AA can be used as a carbon source by C. albicans (Deva
et al., 2000). The authors also identified a HETE produced by
C. albicans from AA namely 3,18-diHETE, that is associated with
hyphal forms and may play a role in adhesion during infection
(Deva et al., 2000; Ells et al., 2012). Additionally, the authors
showed that most AA is metabolized by non-mitochondrial
pathways, concurrent with the speculation that fatty acids are
metabolized by peroxisomal β-oxidation in yeasts. Acetylsalicylic
acid-sensitive 3-HETE (Figure 6B), produced by C. albicans was
also speculated to be linked to C. albicans morphogenesis (Deva
et al., 2001). 3-HETE can also serve as substrate for COX-2
in mammalian cells to form 3-hydroxyeicosanoids due to the
similarity to AA (Ciccoli et al., 2005). Further analysis of one of
these metabolites, 3-OH-PGE2, indicated a similar or even more
robust effect on mammalian cells eliciting a pro-inflammatory
response.
The anti-inflammatory lipid Resolvin E1, which Candida
albicans is able to produce from eicosapentaenoic acid, also
plays a role in the interspecies signaling (Haas-Stapleton et al.,
2007). This compound was shown to protect C. albicans against
host immunity at low doses, however, at higher concentration,
this protective effect is lost. This is thought to facilitate the
commensal carriage of C. albicans as part of the human
microbiome.
An important aspect of the determination of C. albicans
virulence was the identification of a PGE2 cross reactive
compound produced by C. albicans from exogenous AA (Noverr
et al., 2001). This compound was later identified as PGE2,
identical to the host product (Erb-Downward and Noverr, 2007).
This was especially surprising as C. albicans does not possess
homologs to COX present in mammalian cells responsible for
the formation of PGE2. The involvement of various enzymes or
homologous enzymes was speculated in the production of PGE2.
A multicopper oxidase homolog (Fet3), fatty acid desaturase
homolog (Ole2) and cytochrome P450s has been shown to
be involved in the production of PGE2 by C. albicans (Erb-
Downward and Noverr, 2007; Ells et al., 2011; Krause et al.,
2015). Biofilm formation in C. albicans as well as germ tube
formation has been shown to be enhanced by the addition of
synthetic PGE2. In addition, various COX-inhibitors such as ASA
drastically affect the formation of biofilms and germ tubes (Alem
and Douglas, 2004). Interestingly, the simultaneous addition of
PGE2 abolished the inhibitory effect of ASA on C. albicans
biofilm formation. In a later study by the same researchers,
a comparison of PGE2 production by C. albicans planktonic
cells and biofilms showed a significant increase in PGE2
production of C. albicans biofilms (Alem and Douglas, 2005). In
addition, various COX-inhibitors, namely ASA, diclofenac and
etodolac, significantly decreased the production of PGE2 by C.
albicans biofilms. These findings suggest a possible link between
prostaglandin production and biofilm formation. Deva et al.
(2001) reported significant decrease in yeast to hyphal transition
by C. albicans with the addition of ASA. This morphological
effect was attributed to the possible suppression of 3(R)-hydroxy-
oxylipins.
Figure 7 indicates the interaction of C. albicans and P.
aeruginosa with host cells with the focus on eicosanoid
production. In the figure, arrows indicate the production or
increase of an eicosanoid, whereas a question mark indicates an
unknown effect or interaction.
Considering the information regarding the direct and
indirect interaction of C. albicans and P. aeruginosa, as
well as the information regarding the role of eicosanoids
during single species infection, several questions can be
asked relating to polymicrobial infection with C. albicans and
P. aeruginosa.
Role of Oxylipins in Polymicrobial Infection
Although information is available regarding the eicosanoids
produced, and their effect during single species infection,
very little is known regarding the effect of microbially-
produced eicosanoids on co-infecting pathogens, as well as on
the host.
In a study by Peters and Noverr (2013), the role of eicosanoids
during polymicrobial infection in another microbial interaction
became evident. In this study, a murine model was used to
elucidate the effect of polymicrobial interactions usingC. albicans
and Staphylococcus aureus. Through their work, it was evident
that polymicrobial infections with these organisms resulted
in a significant increase in morbidity and mortality during
murine peritoneal infection, with this effect not seen with single
species infection. In addition, disease progression and microbial
load in infected mice was significantly higher, compared to
monomicrobial infections. The authors also detected a significant
increase in pro-inflammatory chemokines released, as well
as recruitment of polymorphonucleocytes. To determine the
effect of the pro-inflammatory response on infection dynamics,
indomethacin was used. Indomethacin, a non-selective COX
inhibitor, similar to ASA, caused a significant reduction in
morbidity and mortality in polymicrobial infection, as well
as a reduction in cytokine release. Indomethacin also caused
a significant reduction in microbial load during co-infection.
This effect was not seen with monomicrobial infection. In vitro
experiments showed that this effect was not due to inhibition of
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FIGURE 7 | Interaction of Candida albicans and Pseudomonas aeruginosa with host cells highlighting the production of eicosanoids. Arrows indicate
production/increase. Question marks indicate uncharacterized interactions (AA, Arachidonic acid; PLA2,Phospholipase A2; PGs, Prostaglandins; PGE2, Prostaglandin
E2; ExoU, Exotoxin U; PYO, pyocyanin; LPS, lipopolysaccharide; 3-HETE, 3-hydroxyeicosatetraenoic acid; 3-oxo-HLS, 3-oxododecanoyl-L-homoserine lactone;
15-LOX, 15-Lipoxygenase).
growth of C. albicans and S. aureus. The authors also observed a
significant increase in PGE2 release by the host cells in response
to polymicrobial infection with indomethacin also causing a
significant reduction in PGE2. The authors suggested that PGE2
may play a role in the non-protective pro-inflammatory response
during polymicrobial infection, as PGE2 induces the release
of several cytokines. To further determine the effect of PGE2
in co-infection, mice were co-infected with C. albicans and
S. aureus and treated with indomethacin as well as PGE2. Under
this circumstance, high morbidity and mortality was observed
in the mice, although they were treated with indomethacin.
In the absence of infection, with only the administration of
indomethacin and PGE2, no mortality was observed. Further,
the administration of PGE2 caused a significant increase in
microbial burden during co-infection. During this study, the
production of eicosanoids, such as PGE2, by C. albicans itself
was not addressed. Interestingly, Krause et al. (2015) indicated
that C. albicans PGE2 production significantly enhances S.
aureus biofilm growth in vitro. The authors also found that
co-incubation of C. albicans with S. aureus did not elicit an
increase in PGE2 production by C. albicans. Nothing is known
yet regarding the eicosanoid production of C. albicans and P.
aeruginosa during co-infection.
CONCLUSIONS
In addition to the ample evidence supporting the interaction
of C. albicans and P. aeruginosa, not only with their host,
but also with each other, it is evident that the interaction is
multifaceted. Various virulence factors such as morphogenesis,
hypermutabililty and secreted factors (including lipid mediators)
affect and damage hosts to facilitate rapid and aggressive
colonization and infection. Any disequilibrium in host defenses,
such as in CF, immune disorders, and breaching of host barriers,
is rapidly exploited by these opportunistic pathogens.
On their own, C. albicans and P. aeruginosa pose a risk to
compromised hosts. Recent studies, however, illuminate that
the interaction of these microorganisms are antagonistic with
substantial damage caused to the host during the chemical war
they play part in. Host immunity also plays a large role in damage
to its own tissue due to radical generation by the innate immune
response and various lipid mediators. This is even more evident
in the work by Peters and Noverr (2013). It is also evident that
various secreted factors of C. albicans (including farnesol and
various hydrolytic enzymes) and P. aeruginosa (including AHL’s,
PQS, PYO and various peptides) form a large amount of radicals
and can elicit oxidative damage to each other, as well as the host.
Although the role of lipid mediators between single pathogens
and hosts has been studied, a gap in knowledge still exists
regarding the effect of lipid mediators in polymicrobial infection
of C. albicans and P. aeruginosa. Polymicrobial infection by C.
albicans and S. aureus, however, highlight the importance of
lipid mediators, such as PGE2, in infection by multiple microbes.
Due to the fact that C. albicans and P. aeruginosa are both
able to produce significant amounts of prostaglandins and other
eicosanoids from exogenous AA, this could affect the dynamics
of this co-infection as well as host survival during infection.
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This warrants investigation to fully understand the interaction of
C. albicans and P. aeruginosa in terms of eicosanoids, as well as
the effect of these eicosanoids in the host during co-infection.
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